Sunshine Biopharma (SBFM) EPS (Basic) Growth (1y) (2018 - 2026)
Sunshine Biopharma (SBFM) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 65.56% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 5.87% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -389.31% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -11.93% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 105.98% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 2,385.12% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -15.37% |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 41.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.90% |
| Dec 31, 2025 | 83.25% |
| Sep 30, 2025 | 106.87% |
| Jun 30, 2025 | 98.16% |
| Mar 31, 2025 | 98.91% |
| Dec 31, 2024 | 96.91% |
| Sep 30, 2024 | 98.14% |
| Jun 30, 2024 | 49.74% |
| Mar 31, 2024 | 74.09% |
| Dec 31, 2023 | 96.79% |
| Sep 30, 2023 | 67.15% |
| Jun 30, 2023 | -4.56% |
| Mar 31, 2023 | 67.01% |
| Dec 31, 2022 | -708.31% |
| Sep 30, 2022 | 95.15% |
| Jun 30, 2022 | 97.16% |
| Mar 31, 2022 | 91.67% |
| Dec 31, 2019 | 1,708.24% |
| Jun 30, 2019 | -74.03% |
| Mar 31, 2019 | 99.13% |